WallStreetZenWallStreetZen

NYSE: ANRO
Alto Neuroscience Inc Stock

$14.99-0.38 (-2.47%)
Updated Jul 19, 2024
ANRO Price
$14.99
Fair Value Price
N/A
Market Cap
$402.99M
52 Week Low
$9.40
52 Week High
$24.00
P/E
N/A
P/B
2.09x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.09
Operating Cash Flow
N/A
Beta
-0.24
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ANRO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ANRO is good value based on its book value relative to its share price (2.09x), compared to the US Biotechnology industry average (6.22x)
P/B vs Industry Valuation
ANRO's short-term assets ($208.31M) exceed its short-term liabilities ($8.01M)
Short-term Liabilities Financials
ANRO's short-term assets ($208.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more ANRO due diligence checks available for Premium users.

Be the first to know about important ANRO news, forecast changes, insider trades & much more!

ANRO News

Valuation

ANRO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.09x
Industry
6.22x
ANRO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ANRO's financial health

Profit margin

Revenue
$0.0
Net Income
-$13.4M
Profit Margin
0%

Assets to liabilities

Assets
$209.9M
Liabilities
$16.8M
Debt to equity
0.09
ANRO's short-term assets ($208.31M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ANRO's short-term assets ($208.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ANRO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.0M
Investing
-$224.0k
Financing
$134.6M

ANRO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ANRO$402.99M-2.47%N/A2.09x
PGEN$401.35M-4.22%-4.08x4.14x
TSHA$400.22M-5.31%-4.37x7.43x
LYEL$397.71M-4.29%-1.73x0.66x
ENGN$397.05M+0.45%-0.06x1.63x

Alto Neuroscience Stock FAQ

What is Alto Neuroscience's quote symbol?

(NYSE: ANRO) Alto Neuroscience trades on the NYSE under the ticker symbol ANRO. Alto Neuroscience stock quotes can also be displayed as NYSE: ANRO.

If you're new to stock investing, here's how to buy Alto Neuroscience stock.

What is the 52 week high and low for Alto Neuroscience (NYSE: ANRO)?

(NYSE: ANRO) Alto Neuroscience's 52-week high was $24.00, and its 52-week low was $9.40. It is currently -37.54% from its 52-week high and 59.47% from its 52-week low.

How much is Alto Neuroscience's stock price per share?

(NYSE: ANRO) Alto Neuroscience stock price per share is $14.99 today (as of Jul 19, 2024).

What is Alto Neuroscience's Market Cap?

(NYSE: ANRO) Alto Neuroscience's market cap is $402.99M, as of Jul 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Alto Neuroscience's market cap is calculated by multiplying ANRO's current stock price of $14.99 by ANRO's total outstanding shares of 26,883,990.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.